CTI BioPharma Corp.
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of CTI BioPharma Corp. generated cash of -$81,194,000, which is more than the previous year. Cash used in financing activities reached the amount of $120,021,000 last year. Net change in cash is therefore -$35,026,000.
Cash Flow
| 2013 | -35.83M | -1.53M | 58.97M |
|---|---|---|---|
| 2014 | -39.55M | -541K | 36.02M |
| 2015 | -95.20M | -78K | 152.01M |
| 2016 | -76.68M | -137K | -7.36M |
| 2017 | -39.29M | -38K | 38.97M |
| 2018 | -39.82M | -30.49M | 63.49M |
| 2019 | -27.82M | 28.13M | -5.60M |
| 2020 | -42.20M | -9.61M | 61.07M |
| 2021 | -84.88M | 12M | 97.94M |
| 2022 | -81.19M | -73.85M | 120.02M |
CTIC Cash Flow Statement (2013 – 2022)
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 65.44M | 40.39M | 31.14M | 36.43M | 43.21M | 44.00M | 128.18M | 70.93M | 71.63M | 50.43M |
Operating activities | ||||||||||
Net income | -92.99M | -97.90M | -52.45M | -40.02M | -29.35M | -40.83M | -52.95M | -120.76M | -94.22M | -43.55M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 1.95M | 526K | 532K | 546K | 593K | 717K | 831K | 990K | 1.1M | 1.57M |
Stock-based compensation expense | 10.03M | 4.74M | 4.31M | 5.16M | 0 | 0 | 0 | 0 | 0 | 9.06M |
| Deferred income tax benefit | 10.03M | 4.74M | 4.31M | 5.16M | 0 | 0 | 0 | 0 | 0 | 9.06M |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | -15.38M | 0 | 0 | 13.67M | -12.38M | 402K | -156K | 1.55M | -1.98M | -227K |
Inventories | -733K | 0 | 0 | 5.46M | -698K | 1.12M | 567K | -402K | 305K | -3.25M |
Accounts payable | 7.73M | 5.58M | -4.69M | -5.46M | 1.86M | -4.73M | -3.02M | 4.36M | 1.45M | -5.77M |
Cash generated by operating activities | -81.19M | -84.88M | -42.20M | -27.82M | -39.82M | -39.29M | -76.68M | -95.20M | -39.55M | -35.83M |
Investing activities | ||||||||||
Purchases Of Investments | -88.85M | 0 | -12.1M | -11.01M | -42.06M | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -25M | 0 | -17K | 0 | -33K | -49K | -137K | -78K | -333K | -1.65M |
Acquisitions Net | 25M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash generated by investing activities | -73.85M | 12M | -9.61M | 28.13M | -30.49M | -38K | -137K | -78K | -541K | -1.53M |
Financing activities | ||||||||||
Common Stock Issued | 56.94M | 59.06M | 66.26M | 0 | 64.17M | 42.66M | -37K | 15.14M | -28K | -105K |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | -314K | -227K | -28K | -105K |
Repayments of term debt | 0 | -6.32M | -5.33M | 0 | -544K | 0 | -5.45M | 0 | -1.52M | 0 |
Cash used in financing activities | 120.02M | 97.94M | 61.07M | -5.60M | 63.49M | 38.97M | -7.36M | 152.01M | 36.02M | 58.97M |
Net Change In Cash | -35.02M | 25.05M | 9.25M | -5.29M | -6.77M | -784K | -84.18M | 57.24M | -706K | 21.20M |
Cash at end of period | 30.42M | 65.44M | 40.39M | 31.14M | 36.43M | 43.21M | 44.00M | 128.18M | 70.93M | 71.63M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |